Inhibition of Cytosolic Phospholipase A2α: Hit to Lead Optimization
Citations Over TimeTop 10% of 2005 papers
Abstract
Compound 1 was previously reported to be a potent inhibitor of cPLA(2)alpha in both artificial monomeric substrate and cell-based assays. However, 1 was inactive in whole blood assays previously used to characterize cyclooxygenase and lipoxygenase inhibitors. The IC(50) of 1 increased dramatically with cell number or lipid/detergent concentration. In an attempt to insert an electrophilic ketone between the indole and benzoic acid moieties, we discovered that increasing the distance between the two moieties gave a compound with activity in the GLU (7-hydroxycoumarinyl-gamma-linolenate) micelle assay, which contains lipid and detergent. Extensive structure-activity relationship work around this lead identified a potent pharmacophore for cPLA(2)alpha inhibition. The IC(50)s between the GLU micelle and rat whole blood assays correlated highly. No correlation was found for other parameters, including lipophilicity or acidity of the required acid functionality. Compounds 25, 39, and 94 emerged as potent, selective inhibitors of cPLA(2)alpha and represent well-validated starting points for further optimization.
Related Papers
- → Taking the Lead on Lead: Tejon Ranch’s Experience Switching to Non-Lead Ammunition(2009)3 cited
- → Non-orebody sources are significant contributors to blood lead of some children with low to moderate lead exposure in a major lead mining community [Sci. Tot. Environ. 181 (1996) 223–230](1996)1 cited
- → Estimating the Contribution of Lead-Based Paint to Soil Lead, Dust Lead, and Childhood Blood Lead(1995)6 cited
- Hit-to-Lead. Enhancing lead generation to accelerate quality compounds into lead optimization. 18-19 July 2005, London, UK.(2005)
- → Lead, Lead-Working Debris, and Lead Sourcing(2022)